Antacids Market Value Rise to Reach USD 11,194.8 Million by 2033 with a 4.9% of CAGR

The global antacids market is set to experience steady growth, with its valuation projected to rise from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, according to a recent report by Future Market Insights. This represents a compound annual growth rate (CAGR) of 4.9% over the forecast period. The rising prevalence of gastrointestinal disorders, increased demand for over-the-counter (OTC) digestive products, and a shift toward self-medication are key factors driving this expansion.

Proton pump inhibitors (PPIs) continue to dominate the antacids market, holding a substantial share of approximately 25.8% as of 2022. These inhibitors have become a preferred choice for managing conditions like heartburn and gastroesophageal reflux disease (GERD), which are on the rise due to changing dietary habits, stress, and sedentary lifestyles. The convenience and accessibility of OTC antacids have further fueled consumer demand.

The growing trend of self-medication and preference for OTC digestive health products is driving market growth. As consumers seek quick, cost-effective relief from gastrointestinal discomfort, the demand for antacids in tablet, liquid, and chewable form continues to increase. Retail pharmacies, online platforms, and supermarkets are playing a pivotal role in making these products more accessible to a broad consumer base.

The antacids market is poised for sustained growth as industry players introduce new formulations and flavors to enhance consumer experience. Pharmaceutical companies are also leveraging e-commerce platforms and direct-to-consumer sales channels to expand their reach. These developments are expected to create new growth opportunities for manufacturers, retailers, and healthcare providers in the coming decade.

Request a Sample of this Report Now:https://www.futuremarketinsights.com/reports/sample/rep-gb-18182

Key Takeaways:

The global antacids market is projected to grow from US$ 6,971.2 million in 2023 to US$ 11,194.8 million by 2033, with a CAGR of 4.9%.
Proton pump inhibitors (PPIs) are leading the market, holding a 25.8% share as of 2022, driven by demand for effective solutions for GERD and heartburn.
Rising cases of gastrointestinal disorders and the growing trend of self-medication are key factors propelling demand for OTC digestive health products.
The introduction of innovative product formulations, combined with increased availability through retail and e-commerce channels, is driving further growth in the global antacids market.
Market Drivers

Increase in Gastrointestinal Disorders: The rising prevalence of conditions such as heartburn and gastroesophageal reflux disease (GERD) is significantly driving the demand for antacids.
Growing Self-Medication Trend: There is an increasing trend towards self-medication, leading to a higher demand for over-the-counter (OTC) digestive products.
Awareness Campaigns: Initiatives aimed at raising awareness about gastrointestinal health and available treatment options are contributing to market growth.
Accessibility of Antacids: The widespread availability of antacid products in pharmacies and retail outlets enhances consumer access and drives sales.

Competitive Landscape

The market for the production of antacids is fragmented, with several competitors. These businesses are employing strategies including collaborations, partnerships, mergers and acquisitions, and new drug releases to satisfy consumer demand and increase their client base.

Recent Development

On 6 June 2023, The US Food and Drug Administration (FDA) gave final approval to Zydus Lifesciences to market Famotidine tablets in dosages of 20 mg and 40 mg.
On 22 February 2023, GSK announced Haleon to be the name of its independent consumer healthcare company.
Similarly, recent developments related to pharmaceutical companies manufacturing antacids have been tracked by the team at Future Market Insights, which are available in the full report.

Key Companies Profiled

Johnson and Johnson
Sanofi S.A.
Bayer AG
Sun Pharmaceuticals Ltd
Zydus Lifesciences
Abbott Laboratories
AstraZeneca plc
Boehringer Ingelheim International GmbH
Dr. Reddy's Laboratories Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Procter & Gamble Company
Reckitt Benckiser Group PLC
Takeda Pharmaceutical Company Limited.
F. Hoffmann-La Roche Ltd
Mylan N.V
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd.
Bristol Myers Squibb Company
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Fresenius Kabi AG
Alkem Labs.

Key Market Segments Covered in Antacids Industry Research

By Drug Class:

Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
Anti-H.Pyrolic Drugs
Prostaglandin Analogous
Others

By Dosage form:

Tablet
Capsules
Powder
Liquid
Others

By Route of Administration:

Oral
Injectable

By Indication:

Gastroesophageal Reflux Disease
Heartburn
Peptic Ulcer
Others

By Distribution channel:

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East and Africa (MEA)

Explore FMI's Related Ongoing Coverage on Healthcare Market Insights Domain:

Airway Clearance Devices System Market - https://www.futuremarketinsights.com/reports/airway-clearance-devices-system-market

Mobile Operating Rooms Market - https://www.futuremarketinsights.com/reports/mobile-operating-rooms-market

Ovulation Microscope Market - https://www.futuremarketinsights.com/reports/ovulation-microscope-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

This release was published on openPR.